Intercept Pharma (ICPT) Announces NEJM Published Results of Phase 3 POISE Trial of Ocaliva for PBC
Tweet Send to a Friend
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced that the New England Journal of Medicine published the key results of the Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
